SK280785B6 - Liečivo s obsahom kreatínfosfátu - Google Patents
Liečivo s obsahom kreatínfosfátu Download PDFInfo
- Publication number
- SK280785B6 SK280785B6 SK683-94A SK68394A SK280785B6 SK 280785 B6 SK280785 B6 SK 280785B6 SK 68394 A SK68394 A SK 68394A SK 280785 B6 SK280785 B6 SK 280785B6
- Authority
- SK
- Slovakia
- Prior art keywords
- mmol
- animals
- group
- week
- treated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9114967A FR2684381B1 (fr) | 1991-12-03 | 1991-12-03 | Composes presentant une liaison amide phosphorique ou une liaison phosphate d'enol pour leur application en tant que substance therapeutiquement active. |
| PCT/FR1992/001118 WO1993010792A1 (fr) | 1991-12-03 | 1992-12-01 | Utilisation de la creatine phosphate ou de l'acide phosphoenol pyruvique pour le traitement des tumeurs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK68394A3 SK68394A3 (en) | 1995-03-08 |
| SK280785B6 true SK280785B6 (sk) | 2000-07-11 |
Family
ID=9419629
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK683-94A SK280785B6 (sk) | 1991-12-03 | 1992-12-01 | Liečivo s obsahom kreatínfosfátu |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5219846A (hu) |
| EP (1) | EP0614366B1 (hu) |
| JP (1) | JP3437574B2 (hu) |
| KR (1) | KR100235893B1 (hu) |
| AT (1) | ATE142499T1 (hu) |
| AU (1) | AU3260093A (hu) |
| BG (1) | BG61595B1 (hu) |
| CA (1) | CA2124793C (hu) |
| CZ (1) | CZ284966B6 (hu) |
| DE (1) | DE69213757T2 (hu) |
| DK (1) | DK0614366T3 (hu) |
| ES (1) | ES2094522T3 (hu) |
| FR (1) | FR2684381B1 (hu) |
| GR (1) | GR3021876T3 (hu) |
| HU (1) | HU216826B (hu) |
| LV (1) | LV11821B (hu) |
| RO (1) | RO115784B1 (hu) |
| RU (1) | RU2097040C1 (hu) |
| SK (1) | SK280785B6 (hu) |
| UA (1) | UA41285C2 (hu) |
| WO (1) | WO1993010792A1 (hu) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994016712A1 (en) * | 1993-01-27 | 1994-08-04 | Amira, Inc. | Creatine phosphate, creatine phosphate analogs, and uses therefor |
| AU6165894A (en) * | 1993-01-28 | 1994-08-15 | Trustees Of The University Of Pennsylvania, The | Use of creatine or analogs for the manufacture of a medicament for inhibiting tumor growth |
| US5714361A (en) * | 1994-02-14 | 1998-02-03 | Indiana University Foundation | Phosphatase/phosphodiesterase enzyme inhibitors and methods |
| US5627172A (en) * | 1994-03-04 | 1997-05-06 | Natural Supplement Association, Incorporated | Method for reduction of serum blood lipids or lipoprotein fraction |
| DE19537494C2 (de) * | 1995-09-25 | 1997-10-02 | Desitin Arzneimittel Gmbh | Kreatin zum Schutz von neuralem Gewebe |
| DE19653225A1 (de) * | 1996-12-20 | 1998-06-25 | Sueddeutsche Kalkstickstoff | Kreatin-pyruvate und Verfahren zu deren Herstellung |
| DE10116589A1 (de) * | 2001-04-03 | 2002-10-10 | Wulf Droege | Anwendung von Kreatin zur Minderung von oxidativem Stress |
| EP1626711A4 (en) * | 2003-05-09 | 2010-10-06 | Univ Pennsylvania | COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER |
| WO2010074591A1 (ru) | 2008-12-24 | 2010-07-01 | Закрытое Акционерное Общество "Beptekc" | Амиды креатина, способ их получения, средство, обладающее нейропротекторным действием |
| RU2428414C2 (ru) | 2009-11-03 | 2011-09-10 | Закрытое Акционерное Общество "Вертекс" | Способ получения амидов креатина |
| WO2016007622A1 (en) * | 2014-07-09 | 2016-01-14 | Sidra Medical and Research Center | Imaging of creatine kinase enzyme expression in cancerous tissues |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8200252L (sv) * | 1982-01-18 | 1983-07-19 | Pharmacia Ab | Farmaceutisk komposition |
| IT1214598B (it) * | 1985-04-17 | 1990-01-18 | Schiapparelli Farma | Uso terapeutico della fosfocreatina. |
| IT1191639B (it) * | 1985-11-11 | 1988-03-23 | Schiapparelli Farma | Composizione farmaceutica contenente fosfocreatina e metodo per preparla |
| US4874882A (en) * | 1986-03-25 | 1989-10-17 | Ube Industries, Ltd. | Process for preparing monosodium phosphoenolpyruvate |
| US4769318A (en) * | 1986-06-03 | 1988-09-06 | Ube Industries, Ltd. | Additive solution for blood preservation and activation |
-
1991
- 1991-12-03 FR FR9114967A patent/FR2684381B1/fr not_active Expired - Lifetime
- 1991-12-20 US US07/811,058 patent/US5219846A/en not_active Expired - Lifetime
-
1992
- 1992-12-01 RU RU9294030808A patent/RU2097040C1/ru not_active IP Right Cessation
- 1992-12-01 AU AU32600/93A patent/AU3260093A/en not_active Abandoned
- 1992-12-01 EP EP93901806A patent/EP0614366B1/fr not_active Expired - Lifetime
- 1992-12-01 UA UA94005324A patent/UA41285C2/uk unknown
- 1992-12-01 SK SK683-94A patent/SK280785B6/sk not_active IP Right Cessation
- 1992-12-01 HU HU9401656A patent/HU216826B/hu not_active IP Right Cessation
- 1992-12-01 AT AT93901806T patent/ATE142499T1/de active
- 1992-12-01 JP JP50989193A patent/JP3437574B2/ja not_active Expired - Fee Related
- 1992-12-01 CZ CZ941343A patent/CZ284966B6/cs not_active IP Right Cessation
- 1992-12-01 DK DK93901806.5T patent/DK0614366T3/da active
- 1992-12-01 KR KR1019940701870A patent/KR100235893B1/ko not_active IP Right Cessation
- 1992-12-01 WO PCT/FR1992/001118 patent/WO1993010792A1/fr active IP Right Grant
- 1992-12-01 CA CA002124793A patent/CA2124793C/en not_active Expired - Fee Related
- 1992-12-01 DE DE69213757T patent/DE69213757T2/de not_active Expired - Lifetime
- 1992-12-01 RO RO94-00930A patent/RO115784B1/ro unknown
- 1992-12-01 ES ES93901806T patent/ES2094522T3/es not_active Expired - Lifetime
-
1994
- 1994-06-01 BG BG98825A patent/BG61595B1/bg unknown
-
1996
- 1996-12-04 GR GR960403287T patent/GR3021876T3/el unknown
-
1997
- 1997-02-05 LV LVP-97-18A patent/LV11821B/lv unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BG98825A (bg) | 1995-05-31 |
| HU9401656D0 (en) | 1994-09-28 |
| CZ284966B6 (cs) | 1999-04-14 |
| HU216826B (hu) | 1999-09-28 |
| CA2124793A1 (en) | 1993-06-10 |
| EP0614366B1 (fr) | 1996-09-11 |
| DE69213757D1 (de) | 1996-10-17 |
| RO115784B1 (ro) | 2000-06-30 |
| CZ134394A3 (en) | 1994-12-15 |
| ES2094522T3 (es) | 1997-01-16 |
| UA41285C2 (uk) | 2001-09-17 |
| CA2124793C (en) | 2005-09-20 |
| RU2097040C1 (ru) | 1997-11-27 |
| JP3437574B2 (ja) | 2003-08-18 |
| BG61595B1 (bg) | 1998-01-30 |
| RU94030808A (ru) | 1996-10-20 |
| LV11821B (en) | 1997-12-20 |
| SK68394A3 (en) | 1995-03-08 |
| DK0614366T3 (da) | 1996-11-25 |
| EP0614366A1 (fr) | 1994-09-14 |
| LV11821A (lv) | 1997-08-20 |
| FR2684381A1 (fr) | 1993-06-04 |
| DE69213757T2 (de) | 1997-04-03 |
| FR2684381B1 (fr) | 1995-05-05 |
| AU3260093A (en) | 1993-06-28 |
| HUT68876A (en) | 1995-08-28 |
| US5219846A (en) | 1993-06-15 |
| JPH07501534A (ja) | 1995-02-16 |
| GR3021876T3 (en) | 1997-03-31 |
| KR100235893B1 (ko) | 1999-12-15 |
| WO1993010792A1 (fr) | 1993-06-10 |
| ATE142499T1 (de) | 1996-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103930166B (zh) | p62小分子化学抑制剂 | |
| SK280785B6 (sk) | Liečivo s obsahom kreatínfosfátu | |
| US11680067B2 (en) | Small molecules for the treatment of primary cancer and cancer metastasis | |
| EP0944389B1 (en) | Purified compositions of 10-propargyl-10-deazaaminopterin and methods of using same in the treatment of tumors | |
| SK138597A3 (en) | A pharmaceutical composition containing n-chlorophenylcarbamates, n-chlorophenylthiocarbamates and n-phosphonoglycine derivatives for inhibiting the growth of cancers and viruses in mammals | |
| US5004735A (en) | Pharmaceutical compositions for the inhibition of tumor metastasis | |
| EP0774255A1 (en) | Use of ursolic acid for the manufacture of a medicament for suppressing metastasis | |
| Presant et al. | Amphotericin B plus 1, 3‐BIS (2‐chloroethyl)‐1‐nitrosourea (BCNU‐NSC NO. 409962) in advanced cancer. Phase I and preliminary phase II results | |
| US20090326224A1 (en) | Thieno pyrimidine compounds | |
| ES2317913T3 (es) | Tratamiento antitumoral combinado que comprende un derivado de la distamicina sustituida por acriloilo y un antimetabolito. | |
| South-East European Oncology Group (SEEOG) et al. | Phase II study of 4′-epi-doxorubicin in patients with untreated, extensive small cell lung cancer | |
| CN114948951B (zh) | Fk506或其可药用衍生物和铁死亡诱导剂或其可药用衍生物联合在制备治疗癌症的药物中的用途 | |
| US5037804A (en) | Agent for preventing and treating thrombocytopenia | |
| EP0585728A1 (en) | Use of dithiolylidene malonate derivatives for the prevention of metastasis | |
| GB2144128A (en) | The tripeptide eisenin and carcinostatic compositions having an immunopotentiating carcinostatic effect which contain it | |
| EP0291594A1 (en) | Pyrazine for use in the treatment of haemodynamic and metabolic disorders | |
| CN114585635A (zh) | 作为抗癌症剂的n-酰化组氨酸二肽 | |
| EP0432630A2 (en) | Antitumor agent | |
| EP1891957A1 (en) | Purified Compositions of 10-Propargyl-10-Deazaaminopterin and Methods of Using Same in the Treament of Tumors | |
| EP0565730A1 (en) | Remedy for hepatic disease | |
| US20040254123A1 (en) | Malignant cell differentiation inducer compositions and utilization of the same | |
| WO1996030024A1 (en) | The pharmaceutical composition containing the 1,3,2-oxazaphosphorinane and mesna for the cancer treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20111201 |